Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Polyphor AG (SW: POLN)

 
POLN Technical Analysis
5
As on 2nd Mar 2022 POLN STOCK Price closed @ 1.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.47 & Strong Sell for SHORT-TERM with Stoploss of 8.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

POLNSTOCK Price

Open 1.30 Change Price %
High 1.32 1 Day 0.01 0.77
Low 1.30 1 Week -0.19 -12.67
Close 1.31 1 Month -0.29 -18.12
Volume 8501 1 Year -6.08 -82.27
52 Week High 8.92 | 52 Week Low 1.30
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
NESN 75.96 -0.73%
NESN 75.96 -0.73%
UBSG 28.14 -0.04%
UBSG 28.14 -0.04%
NOVN 91.56 0.63%
NOVN 91.56 0.63%
PRFN 0.03 50.00%
ARYN 1.46 -0.68%
 
SW Switzerland Top Gainers Stocks
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CASN 1.90 8.57%
SKIN 32.50 8.33%
SKIN 32.50 8.33%
 
SW Switzerland Top Losers Stocks
MBTN 0.33 -15.38%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
HOCN 0.49 -10.91%
 
 
POLN
Daily Charts		 POLN
Intraday Charts		 Whats New @
Bazaartrend		 POLN
Free Analysis
 
POLN Important Levels Intraday
RESISTANCE1.35
RESISTANCE1.34
RESISTANCE1.33
RESISTANCE1.32
SUPPORT1.30
SUPPORT1.29
SUPPORT1.28
SUPPORT1.27
 
POLN Forecast November 2024
Share
4th UP Forecast3.47
3rd UP Forecast2.78
2nd UP Forecast2.35
1st UP Forecast1.92
1st DOWN Forecast0.7
2nd DOWN Forecast0.27
3rd DOWN Forecast-0.16
4th DOWN Forecast-0.85
 
POLN Weekly Forecast
4th UP Forecast4.53
3rd UP Forecast3.50
2nd UP Forecast2.86
1st UP Forecast2.22
1st DOWN Forecast0.40
2nd DOWN Forecast-0.24
3rd DOWN Forecast-0.88
4th DOWN Forecast-1.91
 
POLN Forecast2024
4th UP Forecast16.82
3rd UP Forecast11.85
2nd UP Forecast8.77
1st UP Forecast5.7
1st DOWN Forecast-3.08
2nd DOWN Forecast-6.15
3rd DOWN Forecast-9.23
4th DOWN Forecast-14.2
 
 
POLN Other Details
Segment EQ
Market Capital 21310002.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
POLN Address
POLN
 
POLN Latest News
 
Your Comments and Response on Polyphor AG
 
POLN Business Profile
Polyphor AG, a clinical stage biopharmaceutical company, focuses on developing macrocycle drugs for cancer. Its lead drug candidates include Balixafortide (POL6326), an antagonist of the chemokine receptor CXCR4, which is in Phase III for combination treatment in oncology; POL6014, an inhaled inhibitor of neutrophil elastase, which is in Phase Ib clinical trial for the treatment of cystic fibrosis and other neutrophilic lung diseases; and outer membrane protein targeting antibiotics (OMPTA) platform. The company is also developing POL7306, targeting the most resistant MDR strains of all Gram-negative ESKAPE, including enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa, and enterobacter species pathogens; and inhaled murepavadin (POL7080), a precision outer membrane protein targeting antibiotic for the treatment of pseudomonas aeruginosa. Polyphor AG was founded in 1996 and is headquartered in Allschwil, Switzerland. Address: Hegenheimermattweg 125, Allschwil, Switzerland, 4123
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service